Live Analyst Rating Changes 36623 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Jack Reynolds-Clark
MS

Jack Reynolds-Clark

Morgan Stanley
Wall Street Analyst
★★★★☆
#359
on 13Foresight · ranked by our own returns
62%
Success Rate
+6.6%
Average Return
8 of 13 calls profitable · +63.4% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 62% of Jack Reynolds-Clark's ratings turned a profit when each position was held for 1 year — averaging +6.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

19 Buy 15 Hold 1 Sell
Jack's Stock Coverage 11 ratings · 2026-10-02
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
WILLF
Demant
 Sep 02, 2026 BUY Strong Buy
-6.2% avg upside
19 analysts
$58.84
29.22% Upside
 +3.5% ·
CH:SOON
Sonova Holding AG
 Sep 02, 2026 HOLD Hold
-10.1% avg upside
18 analysts
$245.00
1.89% Downside
 +1.9% ·
DE:AFX
Carl Zeiss Meditec
 Sep 02, 2026 SELL Sell
+47.4% avg upside
13 analysts
$25.88
16.41% Downside
 +3.4% ·
GB:SN
Smith & Nephew
 May 06, 2026 HOLD Buy
+1308.8% avg upside
17 analysts
$1350.00
36.71% Upside
 -9.5% ·
CH:ALC
Alcon
 May 06, 2026 BUY Buy
+34.4% avg upside
36 analysts
$80.00
50.02% Upside
 +5.9% ·
GB:AMS
Advanced Medical Solutions
 Apr 09, 2026 HOLD Buy
-4.9% avg upside
3 analysts
$260.00
7.90% Downside
 +34.5% ·
GB:CTEC
ConvaTec
 Mar 31, 2026 BUY Strong Buy
+38.0% avg upside
18 analysts
 — -4.6% ·
IT:AMP
Amplifon S.p.A.
 Nov 18, 2025 HOLD Buy
+96.1% avg upside
14 analysts
$15.00
24.95% Upside
 -9.4% ·
GB:0QBO
Coloplast A/S
 Aug 22, 2025 HOLD Buy
+75.0% avg upside
17 analysts
$710.00
69.98% Upside
 · ·
GB:0KFH
Revenio
 Apr 11, 2025 BUY Strong Buy
+149.0% avg upside
1 analyst
$28.00
149.03% Upside
 -18.0% ·
GB:OBI
Ondine Biomedical, Inc.
 Feb 21, 2025 BUY Strong Buy
+464.0% avg upside
1 analyst
$55.00
464.01% Upside
 -13.3% ·
🔒 6 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Jack Reynolds-Clark — Frequently Asked Questions
How accurate are Jack Reynolds-Clark's stock ratings?
Based on the calls 13Foresight could measure, about 62% of Jack's ratings were profitable over a one-year hold, with an average return of +6.6% per rating, or +63.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Jack ranked on 13Foresight?
Jack Reynolds-Clark is currently ranked #359 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Jack cover?
Jack most recently has ratings on WILLF, CH:SOON, DE:AFX, GB:SN, CH:ALC, GB:AMS, GB:CTEC, IT:AMP, GB:0QBO, GB:0KFH, GB:OBI. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.